BriaCell Therapeutics Corp. 10-Q filing
Filed 2026-06-09 · Report date 2026-04-30 · 2026
Filing metadata
- Accession number
- 0001493152-26-027928
- Form type
- 10-Q
- CIK
- 0001610820
- Primary document
- https://www.sec.gov/Archives/edgar/data/1610820/000149315226027928/form10-q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BriaCell Therapeutics Corp..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-23.5M | - | - |
| Net Income | $-22.6M | - | - |
| Eps Basic | -5.73 | - | - |
| Eps Diluted | -5.73 | - | - |
| Cash And Equivalents | $6.9M | - | - |
| Total Assets | $27.1M | - | - |
| Operating Cash Flow | $-22.7M | - | - |
| Capital Expenditures | $127,049 | - | - |